Sydney Eye Surgeons offer treatment for wet AMD (age-related macular degeneration) using eye injections that can be performed in the clinic.
Intravitreal injections with an anti-vascular endothelial growth factor (anti-VEGF) drug are a new option for treatment for wet AMD. Anti-VEGF drugs stop vessels from growing. By stopping blood vessels growing and leaking, further damage to your sight is prevented.
The drug is injected into your eye with a fine needle. Minimal discomfort is to be expected.
The injection is given with you lying down comfortably. Local anaesthetic drops are applied to numb your eye and minimise discomfort. Your eyelids and surface of the eye are cleaned to prevent infection. Your face and the area around your eye will be covered by a drape to keep the area sterile. A small clip (speculum) may be used to keep the eye open. Further anaesthetic is given on the surface of the eyeball.
The injection site is marked with callipers and your eye is stabilised with forceps or a cotton bud. A few seconds later, the injection is given. Your vision is assessed post injection by checking hand movements or counting fingers and a final lot of drops are instilled before the drapes are taken off.
Your eye is cleansed with sterile water and you will go home with lubricant eye drops. Most patients require a loading course of three injections at regular intervals of four weeks. After the first three courses of injections, the majority of patients will require further injections depending on the leakiness of the blood vessels. Patients will need to be reviewed at regular intervals (timing to be decided at each visit) when further treatment might be given to maintain the benefits of therapy.
You might notice some discomfort and redness for the first few days after your treatment. This is often due to the nature of the antiseptic used. If your eye becomes progressively red, sensitive to light, swollen and painful, or your vision gets worse after the anti-VEGF treatment, you must seek medical help. This might indicate infection and normally occurs within the first week after the injection, but the risk is minimal.
You should not be given anti-VEGF if you have any of the following conditions:
As with any medical procedure, there is a small risk of complications following anti- VEGF treatment. Most complications that might occur are from the injection itself, rather than the drug. For most patients, the benefit of the treatment outweighs the small risk of injection injury.
The following are the major potential risks and side effects of anti-VEGF injections. These risks are all rare. Significant loss of vision due to this treatment is very uncommon.
If you would like to know more about intravitreal injections, please call our rooms or make an online enquiry.